Summary: The Excelsior XT-27 is a microcatheter used primarily in neurovascular procedures, such as stent delivery and thrombectomy. Key evidence highlights its use in overcoming interference during aneurysm treatment and its feasibility in suction thrombectomy.
The Excelsior XT-27 microcatheter was cleared by the FDA via the 510(k) pathway on April 20, 2012. It is manufactured by Stryker Neurovascular and classified as a Class 2 device under product code DQY.
What It Is
The Excelsior XT-27 is a microcatheter designed for neurovascular interventions, including stent delivery and thrombectomy. It facilitates navigation through cerebral vasculature, aiding in the treatment of conditions like aneurysms and acute occlusions.
Clinical Applications
Commonly used in the jailing technique for aneurysm treatment and in suction thrombectomy for acute distal occlusions, the Excelsior XT-27 is integral in complex neurovascular procedures requiring precise catheter placement.
Evidence Summary
The literature includes three studies from 2016 to 2020, comprising case series and initial experiences. These studies explore the device's application in aneurysm treatment and thrombectomy, highlighting its practical utility.
Reported Outcomes
Published studies report successful use of the Excelsior XT-27 in overcoming microcatheter interference during aneurysm treatment and achieving complete recanalization in distal occlusions via suction thrombectomy. The device's design facilitates complex neurovascular procedures.
Safety Profile
Reported complications include potential interference between microcatheters during the jailing technique. However, no significant adverse events were highlighted in the available studies, indicating a favorable safety profile.
Evidence Limitations
The evidence is limited by the small number of studies and lack of large-scale randomized controlled trials. Further research is needed to confirm long-term outcomes and safety across diverse patient populations.
Frequently Asked Questions
What are the clinical indications for Excelsior XT-27 microcatheter?
The Excelsior XT-27 is indicated for use in neurovascular procedures, including stent delivery in aneurysm treatment and suction thrombectomy for acute distal occlusions.
What outcomes have been reported in clinical studies?
Studies report successful stent delivery in aneurysm treatment and effective recanalization in thrombectomy procedures, highlighting the device's efficacy in complex neurovascular interventions.
What complications have been reported?
Reported complications include potential interference between microcatheters during certain procedures, though no significant adverse events were noted in the studies reviewed.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.